ArticlemBio2024
Open access · goldAbstract read
In one paragraph
Article in mBio, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.
0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
10.1field-weighted citation impact, top 1% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
26 citing papers in PubMed, 27 citations in OpenAlex.
- Set202 is a histone lysine methyltransferase that enablesbioRxiv : the preprint server for biology · 2026Article
- Tissue-Resident Macrophages: Linking Physiology and Inflammation in Infection.Clinical reviews in allergy & immunology · 2026Review
- Article
- Article
- Review of the Microbial Spectrum of Mixed Respiratory Fungal Infections.Journal of epidemiology and global health · 2026Review
- Use of a human immortalized microglia cell line to study recognition, phagocytosis, and intracellular survival ofmSphere · 2026Article
- Microglia sense fungal infections through capsular components from capillary-bound Cryptococcus neoformans via endothelial nucleotide signaling.PLoS biology · 2026Article
- Clinical characteristics and etiological analysis of deep fungal infections in a general hospital in Southwest China (2020-2024).Frontiers in public health · 2026Article
- Reconsidering the blood-brain barrier: histopathology and microanatomy of cryptococcal CNS infection.Microbiology and molecular biology reviews : MMBR · 2025Review
- In vitro and in vivo efficacy of the antimycobacterial molecule SQ109 against the human pathogenic fungus, Cryptococcus neoformans.PLoS neglected tropical diseases · 2025Article
- Article
- Article
- Brain-infiltrating CD4 T cells drive inflammatory microglia proliferation during cryptococcal meningitis in mice.Nature communications · 2025Article
- 1,5-Diarylidene-4-Piperidones as Promising Antifungal Candidates AgainstAntibiotics (Basel, Switzerland) · 2025Article
- Article
- Roles of TLR9: Gatekeeper to fungal infections.PLoS pathogens · 2025Article
- Active Cryptococcus neoformans glucuronoxylomannan production prevents elimination of cryptococcal CNS infection in vivo.Journal of neuroinflammation · 2025Article
- Transcription Factors Fzc9 and Pdr802 Regulate ATP Levels and Metabolism inInternational journal of molecular sciences · 2025Article
- Insight into the Mechanisms and Clinical Relevance of Antifungal Heteroresistance.Journal of fungi (Basel, Switzerland) · 2025Review
- Research progress on immunometabolism and gut microbiota in cryptococcal meningitis: mechanisms and therapeutic implications.Frontiers in neuroscience · 2025Review
Corrections and comments
- Commented on by
- Update of
Authors and funding
13 authors at 2 institutions in 2 countries.
Vanessa I FrancisMRC Centre for Medical Mycology at University of Exeter, University of Exeter, Exeter, United Kingdom.
Corin LiddleBioimaging Facility, University of Exeter, Exeter, United Kingdom.ORCID 0009-0001-8059-1730
Emma CamachoJohns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
Madhura KulkarniJohns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
Samuel R S JuniorJohns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
Jamie A HarveyMRC Centre for Medical Mycology at University of Exeter, University of Exeter, Exeter, United Kingdom.
Elizabeth R BallouMRC Centre for Medical Mycology at University of Exeter, University of Exeter, Exeter, United Kingdom.ORCID 0000-0001-8051-2302
Darren D ThomsonMRC Centre for Medical Mycology at University of Exeter, University of Exeter, Exeter, United Kingdom.
Gordon D BrownMRC Centre for Medical Mycology at University of Exeter, University of Exeter, Exeter, United Kingdom.ORCID 0000-0002-0287-5383
J Marie HardwickJohns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.ORCID 0000-0002-4847-2045
Arturo CasadevallJohns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.ORCID 0000-0002-9402-9167
Jonathan WittonFaculty of Health and Life Sciences, University of Exeter, Exeter, United Kingdom.
Carolina CoelhoMRC Centre for Medical Mycology at University of Exeter, University of Exeter, Exeter, United Kingdom.ORCID 0000-0002-7523-3031
University of Exeter · GBJohns Hopkins University · US
Funding
Rapid production of SARS-CoV-2 molecular clones using CRISPR-based yeast recombineeringR01AI100272 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MADHANI, HITEN D · 2012 to 2025
$11.3MSynergy of Host Defense Mechanisms in the LungR01HL059842 · NHLBI · YESHIVA UNIVERSITY · PI CASADEVALL, ARTURO · 1997 to 2023
$7.4MBiology of Fungal MelaninR01AI052733 · NIAID · YESHIVA UNIVERSITY · PI CASADEVALL, ARTURO · 2003 to 2019
$6.6MConjugate vaccines for prevention and treatment of cryptococcosis - COVID-19 Revision SupplementR01AI152078 · NIAID · JOHNS HOPKINS UNIVERSITY · PI CASADEVALL, ARTURO · 2020 to 2024
$5.1MStress-induced cell death mechanisms of fungiR21AI144373 · NIAID · JOHNS HOPKINS UNIVERSITY · PI HARDWICK, J. MARIE · 2020 to 2021
$450kMolecular mechanisms of a neurodevelopmental seizure disorderR21NS127076 · NINDS · JOHNS HOPKINS UNIVERSITY · PI HARDWICK, J. MARIE · 2022 to 2023
$450kCell death pathway leading to vacuole permeabilizationR21AI183596 · NIAID · JOHNS HOPKINS UNIVERSITY · PI HARDWICK, J. MARIE · 2024 to 2025
$444kConservation of programmed cell death across speciesR56AI168539 · NIAID · JOHNS HOPKINS UNIVERSITY · PI HARDWICK, J. MARIE · 2022 to 2022
$409kMRC Centre for Medical Mycology at the University of Exeter MR/N006364/2MRC Centre for Medical Mycology at the University of Exeter MR/V033417/1NHLBI NIH HHS R01 HL059842NIAID NIH HHS R01 AI052733NIAID NIH HHS R01 AI100272NIAID NIH HHS R01 AI152078NIAID NIH HHS R21 AI144373NIAID NIH HHS R21 AI183596NIAID NIH HHS R56 AI168539NIH HHS AI052733-16NIH HHS AI152078-01NIH HHS HL059842-19NIHR Exeter Biomedical Research CentreNINDS NIH HHS R21 NS127076Wellcome TrustWellcome Trust 217163/Z/19/ZWellcome Trust Institutional Strategic Support Award WT105618MA
Abstract
PubMed holds no abstract for this paper.
Indexed as
Acquired Immunodeficiency SyndromeCryptococcosisCryptococcus neoformansMeningitisAnimalsBrainMammalsMiceMicrogliablood-brain barrierCryptococcus neoformansmicroglia
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.